Gut microbiota and short-chain fatty acids in idiopathic REM sleep behavior disorder and Parkinson’s disease
Frontiers in Neurology · 03.11.2026 · 17
DOI: 10.3389/fneur.2026.1982942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Neurology, online erschienen am 03.11.2026. Verfasst von Xianqian Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Parkinson Disease, REM Sleep Behavior Disorder, Fatty Acids, Volatile, Gastrointestinal Microbiome. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Idiopathic rapid eye movement sleep behavior disorder (iRBD) is a prodromal stage of Parkinson’s disease (PD). This study aimed to investigate whether gut microbiota and short-chain fatty acids (SCFAs) show consistent alterations in iRBD and PD with RBD patients.
Methods
We enrolled 29 iRBD, 24 PD with RBD, 17 PD without RBD, and 18 normal controls (NC). Fecal microbiota composition was analyzed via 16S rRNA sequencing, and SCFA concentrations via gas chromatography–mass spectrometry (GC–MS). Clinical symptoms were assessed using motor and non-motor scales, and Spearman correlation analysis was performed to explore interrelationships.
Results
Microbiota analysis revealed that, compared with NC, Bifidobacterium , Blautia_A , and Azospira_A were significantly enriched, whereas Agathobaculum , Clostridium_Q , Faecalibaculum , Photobacterium , Copromonas , UBA3402 , Acetobacter , and Sutterella were reduced in both iRBD and PD with RBD groups. SCFA analysis showed significantly decreased fecal butyric acid and propionic acid levels in both groups versus NC. Correlation analysis demonstrated that in the iRBD group, Bifidobacterium positively correlated with RBD disease duration; butyric acid negatively correlated with NMSS and RBD-HK; propionic acid negatively correlated with NMSS, RBD-HK, and SCOPA-AUT. In the PD with RBD group, Bifidobacterium negatively correlated with SCOPA-AUT and positively with HAMD-17; butyric acid positively correlated with MDS-UPDRS III. Conclusion iRBD and PD with RBD share similar gut dysbiosis and SCFA abnormalities. Elevated Bifidobacterium and decreased butyric acid and propionic acid are candidate markers for iRBD risk stratification, but correlation does not imply predictive ability. Their value in predicting progression to PD requires validation in longitudinal iRBD cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, China.
- Department of Neurology, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou Normal University, Huzhou, Zhejiang, China.
Zitieren
APA
Sun, X., Ye, W., Liu, Y., Sun, X., & Tang, H. (2026). Gut microbiota and short-chain fatty acids in idiopathic REM sleep behavior disorder and Parkinson’s disease. Frontiers in Neurology, 17. https://doi.org/10.3389/fneur.2026.1982942
Vancouver
Sun X, Ye W, Liu Y, Sun X, Tang H. Gut microbiota and short-chain fatty acids in idiopathic REM sleep behavior disorder and Parkinson’s disease. Frontiers in Neurology. 2026;17. doi:10.3389/fneur.2026.1982942
BibTeX
@article{Sun2026,
author = {Sun, Xianqian and Ye, Weidong and Liu, Ying and Sun, Xiaoyan and Tang, Haiyan},
title = {Gut microbiota and short-chain fatty acids in idiopathic REM sleep behavior disorder and Parkinson’s disease},
journal = {Frontiers in Neurology},
year = {2026},
volume = {17},
doi = {10.3389/fneur.2026.1982942}
}
EUVIMED